These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9015279)
1. Detection of IgG antibody to Epstein-Barr virus viral capsid antigen in saliva by antibody capture radioimmunoassay. Vyse AJ; Knowles WA; Cohen BJ; Brown DW J Virol Methods; 1997 Jan; 63(1-2):93-101. PubMed ID: 9015279 [TBL] [Abstract][Full Text] [Related]
2. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus. Nadala EC; Tan TM; Wong HM; Ting RC J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies]. Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. Crowcroft NS; Vyse A; Brown DW; Strachan DP J Epidemiol Community Health; 1998 Feb; 52(2):101-4. PubMed ID: 9578856 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of an antibody capture ELISA for detection of IgG to Epstein-Barr virus in oral fluid samples. Sheppard C; Cohen B; Andrews N; Surridge H J Virol Methods; 2001 Apr; 93(1-2):157-66. PubMed ID: 11311354 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children. Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119 [TBL] [Abstract][Full Text] [Related]
8. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. Linde A; Andersson J; Lundgren G; Wahren B J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317 [TBL] [Abstract][Full Text] [Related]
9. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
10. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR. Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098 [TBL] [Abstract][Full Text] [Related]
11. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
12. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation. Gray JJ J Virol Methods; 1995 Mar; 52(1-2):95-104. PubMed ID: 7769043 [TBL] [Abstract][Full Text] [Related]
13. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351 [TBL] [Abstract][Full Text] [Related]
14. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18. Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457 [TBL] [Abstract][Full Text] [Related]
15. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. Obel N; Høier-Madsen M; Kangro H APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671 [TBL] [Abstract][Full Text] [Related]
16. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia. Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785 [TBL] [Abstract][Full Text] [Related]
17. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726 [TBL] [Abstract][Full Text] [Related]
18. A new Combi test for simultaneous detection of antibodies to viral capsid, early and EBNA antigens of Epstein-Barr virus. Dobec M Zentralbl Bakteriol; 1993 Jun; 278(4):553-61. PubMed ID: 8394757 [TBL] [Abstract][Full Text] [Related]
19. Seroepidemiological study of Epstein-Barr virus infection in Bangladesh. Haque T; Iliadou P; Hossain A; Crawford DH J Med Virol; 1996 Jan; 48(1):17-21. PubMed ID: 8825705 [TBL] [Abstract][Full Text] [Related]
20. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Parry JV; Perry KR; Mortimer PP Lancet; 1987 Jul; 2(8550):72-5. PubMed ID: 2885575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]